Mahmoud Abbas
Overview
Explore the profile of Mahmoud Abbas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
409
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hommerding O, Bernhardt M, Kreft T, Scherping A, Abbas M, Baretton G, et al.
Virchows Arch
. 2024 Dec;
PMID: 39653828
The prognostication of individual disease trajectory and selection of optimal therapy in patients with localized, low-grade prostate cancer often presents significant difficulty. The phosphatase and tensin homolog on chromosome 10...
2.
Lifshitz K, Savin Z, Bashi T, Dekalo S, Hendel H, Ehrlich Y, et al.
Urol Int
. 2024 Oct;
:1-8.
PMID: 39362201
Introduction: The workload for benign prostatic hyperplasia (BPH) surgery is expected to rise with an increase in life expectancy and a growing population. Surgical modalities for BPH have evolved, shifting...
3.
Eminaga O, Lau H, Shkolyar E, Wardelmann E, Abbas M
PLoS One
. 2024 Jul;
19(7):e0305135.
PMID: 39083547
Smoke exposure is associated with bladder cancer (BC). However, little is known about whether the histologic changes of BC can predict the status of smoke exposure. Given this knowledge gap,...
4.
Abbas M, Ramspott J, Chourio Barboza D, Pascher A, Wardelmann E, Sporn J
Oncol Lett
. 2024 May;
28(1):308.
PMID: 38784603
Peritoneal carcinomatosis is one of the leading causes of death in patients with gastrointestinal cancer. Newer locoregional treatment concepts include pressurized intraperitoneal aerosol chemotherapy (PIPAC), the regional application of pressurized...
5.
Klumper N, Tran N, Zschabitz S, Hahn O, Buttner T, Roghmann F, et al.
J Clin Oncol
. 2024 Apr;
42(20):2446-2455.
PMID: 38657187
Purpose: The anti-NECTIN4 antibody-drug conjugate enfortumab vedotin (EV) is approved for patients with metastatic urothelial cancer (mUC). However, durable benefit is only achieved in a small, yet uncharacterized patient subset....
6.
Eminaga O, Abbas M, Kunder C, Tolkach Y, Han R, Brooks J, et al.
Sci Rep
. 2024 Mar;
14(1):5284.
PMID: 38438436
Prostate cancer pathology plays a crucial role in clinical management but is time-consuming. Artificial intelligence (AI) shows promise in detecting prostate cancer and grading patterns. We tested an AI-based digital...
7.
Musa A, Miller S, Amado A, Abbas M, Kayder O, Newberger S, et al.
Cardiovasc Intervent Radiol
. 2023 Dec;
47(1):146-147.
PMID: 38082021
No abstract available.
8.
Abbas M, Heitplatz B, Bernemann C, Boegemann M, Trautmann M, Schrader A, et al.
Oncol Lett
. 2023 Nov;
26(6):527.
PMID: 38020299
In metastatic or locally advanced urothelial carcinoma (UC), therapeutic options have been limited to chemotherapy and immune checkpoint inhibitors. Novel targets and drugs such as antibody drug conjugates have been...
9.
Eminaga O, Leyh-Bannurah S, Shariat S, Krabbe L, Lau H, Xing L, et al.
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894365
Muscle-invasive bladder cancer (MIBC) is a highly heterogeneous and costly disease with significant morbidity and mortality. Understanding tumor histopathology leads to tailored therapies and improved outcomes. In this study, we...
10.
Abbas M, Lai Z, Jansen J, Tu H, Alqudah M, Xu X, et al.
Sci Adv
. 2023 Oct;
9(40):eadi6838.
PMID: 37792942
dispersed from Africa into Eurasia multiple times in the Middle and Late Pleistocene. The route, across northeastern Africa into the Levant, is a viable terrestrial corridor, as the present harsh...